Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Notice: Prescription Drug List (PDL): Multiple Additions Date: October 7, 2019 Our file number: 19-119291-196 The purpose of this Notice of Amendment is to notify about the additions of acalabrutinib, galcanezumab, larotrectinib, mannitol, neratinib, niraparib, ravulizumab,…
Notice: Prescription Drug List (PDL): Multiple Additions Date: July 8, 2019 Our file number: 19-113709-160 The purpose of this Notice of Amendment is to notify about the additions of abemaciclib, cemiplimab, patisiran, and risankizumab to the Prescription Drug List (PDL) for…
Notice: Prescription Drug List (PDL): Multiple Additions Date: March 28, 2019 Our file number: 19-106933-519 The purpose of this Notice of Amendment is to notify about the additions of axicabtagene ciloleucel, cenegermin, dacomitinib. enasidenib, and lorlatinib to the…
Notice: Prescription Drug List (PDL): Multiple Additions Date: March 5, 2019 Our file number: 19-104186-899 The purpose of this Notice of Amendment is to notify about the additions of: celiponase alfa, decitabine, isavuconazole and safinamide to the Prescription Drug List (PDL)…
Notice: Prescription Drug List (PDL): Multiple additions - December 27, 2018 December 27, 2018 Our file number: 18-121421-216 The purpose of this Notice of Amendment is to notify about the additions of Pralatrexate, Elagolix, Dinutuximab, Suvorexant, Elvitegravir, Cobicistat and…
Notice: Prescription Drug List (PDL): Human and Veterinary Antimicrobials November 30, 2018 Our file number: 18-118591-617 The purpose of this Notice of Amendment is to notify that Health Canada has amended 14 antimicrobial active ingredients or their salts or derivatives from…
Notice: Prescription Drug List (PDL): Multiple additions Date: November 1, 2018 Our file number: 18-116661-578 The purpose of this Notice of Amendment is to notify about the additions of Cabozantinib, Doravirine, Inotersen, Lanadelumab, Patiromer, Telotristat, and Zaleplon to the…
Notice of Amendment: Prescription Drug List (PDL): Phytocannabinoids Date: October 17, 2018 Our file number: 18-114531-372 The purpose of this Notice of Amendment is to notify that Health Canada has added phytocannabinoids to the Human and Veterinary Prescription Drug Lists…
Notice: Prescription Drug List: Multiple additions July 4, 2018 Our file number: 18-107885-978 The purpose of this Notice of Amendment is to notify about the additions of Crisaborole and Ertugliflozin to the Human and/or Veterinary Prescription Drug Lists (PDL). These additions…
Notice: Prescription Drug List: Multiple additions May 11, 2018 Our file number: 18-105015-690 The purpose of this Notice of Amendment is to notify about the additions of Benralizumab, Brodalumab, Cidofovir, Flibanserin, Halofuginone (veterinary only), Inotuzumab ozogamicin,…
Early release: coverage and features are still expanding.
